Wave Life Sciences (WVE) Equity Average: 2015-2025
Historic Equity Average for Wave Life Sciences (WVE) over the last 10 years, with Sep 2025 value amounting to $131.9 million.
- Wave Life Sciences' Equity Average rose 90.94% to $131.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $131.9 million, marking a year-over-year increase of 90.94%. This contributed to the annual value of $124.6 million for FY2024, which is 4662.26% up from last year.
- Per Wave Life Sciences' latest filing, its Equity Average stood at $131.9 million for Q3 2025, which was down 15.19% from $155.5 million recorded in Q2 2025.
- Over the past 5 years, Wave Life Sciences' Equity Average peaked at $190.7 million during Q1 2025, and registered a low of -$46.1 million during Q3 2023.
- Over the past 3 years, Wave Life Sciences' median Equity Average value was $32.5 million (recorded in 2024), while the average stood at $57.9 million.
- In the last 5 years, Wave Life Sciences' Equity Average slumped by 448.90% in 2023 and then spiked by 41,122.78% in 2024.
- Quarterly analysis of 5 years shows Wave Life Sciences' Equity Average stood at $31.2 million in 2021, then crashed by 179.50% to -$24.8 million in 2022, then spiked by 98.27% to -$428,000 in 2023, then spiked by 41,122.78% to $175.6 million in 2024, then spiked by 90.94% to $131.9 million in 2025.
- Its last three reported values are $131.9 million in Q3 2025, $155.5 million for Q2 2025, and $190.7 million during Q1 2025.